177 related articles for article (PubMed ID: 33846571)
1. Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation.
Watson MJ; Berger PL; Banerjee K; Frank SB; Tang L; Ganguly SS; Hostetter G; Winn M; Miranti CK
Oncogene; 2021 May; 40(18):3260-3272. PubMed ID: 33846571
[TBL] [Abstract][Full Text] [Related]
2. Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.
Berger PL; Frank SB; Schulz VV; Nollet EA; Edick MJ; Holly B; Chang TT; Hostetter G; Kim S; Miranti CK
Cancer Res; 2014 Jun; 74(12):3357-68. PubMed ID: 24762396
[TBL] [Abstract][Full Text] [Related]
3. Miz1, a Novel Target of ING4, Can Drive Prostate Luminal Epithelial Cell Differentiation.
Berger PL; Winn ME; Miranti CK
Prostate; 2017 Jan; 77(1):49-59. PubMed ID: 27527891
[TBL] [Abstract][Full Text] [Related]
4. SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer.
Yan R; He L; Li Z; Han X; Liang J; Si W; Chen Z; Li L; Xie G; Li W; Wang P; Lei L; Zhang H; Pei F; Cao D; Sun L; Shang Y
Genes Dev; 2015 Mar; 29(6):672-85. PubMed ID: 25792601
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated co-expression of ING4 and PTEN cooperatively enhances their antitumor activity in human hepatocellular carcinoma cells.
Rakshit N; Yang S; Zhou W; Xu Y; Deng C; Yang J; Yu H; Wei W
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):704-13. PubMed ID: 27421660
[TBL] [Abstract][Full Text] [Related]
6. Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.
Shatnawi A; Malkaram SA; Fandy T; Tsouko E
Mol Cell Biochem; 2020 Jan; 464(1-2):153-167. PubMed ID: 31773467
[TBL] [Abstract][Full Text] [Related]
7. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
8. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.
Choi N; Zhang B; Zhang L; Ittmann M; Xin L
Cancer Cell; 2012 Feb; 21(2):253-65. PubMed ID: 22340597
[TBL] [Abstract][Full Text] [Related]
9. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated ING4/PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells.
Wang Y; Yang J; Sheng W; Xie Y; Liu J
Int J Oncol; 2015 Mar; 46(3):1295-303. PubMed ID: 25571952
[TBL] [Abstract][Full Text] [Related]
11. Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
Park JW; Lee JK; Phillips JW; Huang P; Cheng D; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4482-7. PubMed ID: 27044116
[TBL] [Abstract][Full Text] [Related]
12. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
13. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells].
Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC
Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734
[TBL] [Abstract][Full Text] [Related]
14. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
[TBL] [Abstract][Full Text] [Related]
15. High fat diet promotes prostatic basal-to-luminal differentiation and accelerates initiation of prostate epithelial hyperplasia originated from basal cells.
Kwon OJ; Zhang B; Zhang L; Xin L
Stem Cell Res; 2016 May; 16(3):682-91. PubMed ID: 27107344
[TBL] [Abstract][Full Text] [Related]
16. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
17. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.
Kwon OJ; Zhang L; Ittmann MM; Xin L
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):E592-600. PubMed ID: 24367088
[TBL] [Abstract][Full Text] [Related]
18. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model.
Korsten H; Ziel-van der Made A; Ma X; van der Kwast T; Trapman J
PLoS One; 2009 May; 4(5):e5662. PubMed ID: 19461893
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
[TBL] [Abstract][Full Text] [Related]
20. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
